CliffBio
small molecule

DONEPEZIL HYDROCHLORIDE

DONEPEZIL HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyOsmotica Pharmaceutical →See this company's full patent-cliff portfolio

Drug detail

Brand nameDONEPEZIL HYDROCHLORIDE
Active ingredientDONEPEZIL HYDROCHLORIDE
Strength23MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalJanuary 2016
Marketing statusDISCN

More from Osmotica Pharmaceutical

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

DONEPEZIL HYDROCHLORIDE patent cliff — loss of exclusivity — | CliffBio